The Transportation Security Administration (TSA) announced that all flights now permit pediatric epilepsy drugs that contain cannabidiol (CBD). The TSA’s guidelines have been officially adjusted to include language that permits “products/medications that contain hemp-derived CBD or are approved by the FDA are legal as long as it is produced within the regulations define by the law under the Agriculture Improvement Act 2018.”
The agency continued on this policy, that while it still deems other cannabis-infused products illegal as it is under federal law, it “was made aware of an FDA-approved drug that contains CBD oil for children who experience seizures from pediatric epilepsy.” CBD oil that is derived or extracted from hemp is completely legal and has been since the Farm Bill of 2018 classified hemp as an agricultural commodity. Epidiolex is the anti-seizure medication for children which utilizes a hemp-derived CBD component that the agency referred to.
The Transportation Security Administration, in a statement to a cannabis publication, stated: “To avoid confusion as to whether families can travel with this drug, TSA immediately updated TSA.gov once we became aware of the issue.”
The Food and Drug Administration (FDA) is set to hold a public hearing to decide further regulations of CBD on Friday, May 31st.
Curious about how you can make money investing in cannabis? Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We’ll keep you informed on all things cannabis and even help you determine which cannabis companies have the highest growth potential.